Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000022 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 8, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
181,155
Total Value
$1,455,825.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Apr 6, 2026 | Exercise/Conversion | 14,722 | $7.27 | $107,028.94 | 461,924 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 6, 2026 | Sale | 19,060 | $14.33 | $273,129.80 | 442,864 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 7, 2026 | Exercise/Conversion | 14,722 | $7.27 | $107,028.94 | 457,586 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 7, 2026 | Sale | 19,060 | $13.56 | $258,453.60 | 438,526 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 8, 2026 | Exercise/Conversion | 14,722 | $7.27 | $107,028.94 | 453,248 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 8, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 465,129 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 8, 2026 | Sale | 30,841 | $14.83 | $457,372.03 | 434,288 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 8, 2026 | Sale | 100 | $15.48 | $1,548.00 | 434,188 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 6, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 66,997 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 7, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 52,275 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 8, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 37,553 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 8, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 391,658 | Direct | โ | View Details |